Foghorn Therapeutics Inc. (FHTX) › Shareholders' EquityFoghorn Therapeutics Inc. (FHTX) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2018: -$39.27M2019: -$88.02M2020: $146.19M2021: $96.87M2022: $112.0K2023: -$77.19M2024: -$45.53M2025: -$108.50M-$108.50M2018Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025-$108.50M-138.3%2024-$45.53M+41.0%2023-$77.19M-69019.6%2022$112.0K-99.9%2021$96.87M-33.7%2020$146.19M+266.1%2019-$88.02M-124.1%2018-$39.27M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share